Carregant...
Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
Background: Although the introduction of protease inhibitor bortezomib (BTZ) and immunomodulatory agent lenalidomide has led to improved outcomes in patients with multiple myeloma (MM), the disease remains incurable. Gambogenic acid (GNA), a polyprenylated xanthone isolated from the traditional Chin...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381173/ https://ncbi.nlm.nih.gov/pubmed/28382147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17657 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|